Biblioteca Humberto Rosselli Quijano
Información del autor
Autor James M. Youakim |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaAdjunctive armodafinil for major depressive episodes associated with bipolar I disorder / Joseph R. Calabrese en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 10 (Octubre)
Título : Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder : a randomized, multicenter, double blind, placebo controlled, proof of concept study Tipo de documento: texto impreso Autores: Joseph R. Calabrese, Autor ; Terence A. Ketter, Autor ; James M. Youakim, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1363-1370 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Benzodiazepinas, Trastorno bipolar, Trastorno depresivo mayor, Resistencia a los medicamentos, Farmacoterapia, Acido valproico. Resumen: To evaluate the efficacy and safety of armodafinil, the longer-lasting isomer of modafinil, when used adjunctively in patients with bipolar depression.
In this 8-week, multicenter, randomized, double-blind, placebo-controlled study conducted between June 2007 and December 2008, patients who were experiencing a major depressive episode associated with bipolar I disorder (according to DSM-IV-TR criteria) despite treatment with lithium, olanzapine, or valproic acid were randomly assigned to adjunctive armodafinil 150 mg/d (n = 128) or placebo (n = 129) administered once daily in the morning.Link: ./index.php?lvl=notice_display&id=28248
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1363-1370[artículo] Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder : a randomized, multicenter, double blind, placebo controlled, proof of concept study [texto impreso] / Joseph R. Calabrese, Autor ; Terence A. Ketter, Autor ; James M. Youakim, Autor . - 2022 . - pp. 1363-1370.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1363-1370
Palabras clave: Antidepresivos, Benzodiazepinas, Trastorno bipolar, Trastorno depresivo mayor, Resistencia a los medicamentos, Farmacoterapia, Acido valproico. Resumen: To evaluate the efficacy and safety of armodafinil, the longer-lasting isomer of modafinil, when used adjunctively in patients with bipolar depression.
In this 8-week, multicenter, randomized, double-blind, placebo-controlled study conducted between June 2007 and December 2008, patients who were experiencing a major depressive episode associated with bipolar I disorder (according to DSM-IV-TR criteria) despite treatment with lithium, olanzapine, or valproic acid were randomly assigned to adjunctive armodafinil 150 mg/d (n = 128) or placebo (n = 129) administered once daily in the morning.Link: ./index.php?lvl=notice_display&id=28248
Título : Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants : a phase 3, randomized, double-blind study Tipo de documento: texto impreso Autores: Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor Fecha de publicación: 2020 Artículo en la página: pp.1232-1240 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas, Tiofenos. Resumen: To evaluate efficacy, safety, and tolerability of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (as defined by DSM-IV-TR criteria) with inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21881
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1232-1240[artículo] Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants : a phase 3, randomized, double-blind study [texto impreso] / Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor . - 2020 . - pp.1232-1240.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1232-1240
Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas, Tiofenos. Resumen: To evaluate efficacy, safety, and tolerability of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (as defined by DSM-IV-TR criteria) with inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21881
Título : Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants : a phase 3, randomized, double-blind study Tipo de documento: texto impreso Autores: Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor Fecha de publicación: 2020 Artículo en la página: pp.1232-1240 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas, Tiofenos. Resumen: To evaluate efficacy, safety, and tolerability of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (as defined by DSM-IV-TR criteria) with inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21882
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1232-1240[artículo] Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants : a phase 3, randomized, double-blind study [texto impreso] / Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor . - 2020 . - pp.1232-1240.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1232-1240
Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas, Tiofenos. Resumen: To evaluate efficacy, safety, and tolerability of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (as defined by DSM-IV-TR criteria) with inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21882
Título : Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder : A phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants Tipo de documento: texto impreso Autores: Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor Fecha de publicación: 2020 Artículo en la página: pp.1224-1231 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas,Tiofenos. Resumen: To assess the efficacy, tolerability, and safety of brexpiprazole as adjunctive therapy to antidepressant treatments (ADTs) in adults with major depressive disorder (as defined by DSM-IV-TR criteria) and inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21880
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1224-1231[artículo] Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder : A phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants [texto impreso] / Michael E. Thase, Autor ; James M. Youakim, Autor ; Aleksandar Skuban, Autor . - 2020 . - pp.1224-1231.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.9 (Septiembre) . - pp.1224-1231
Palabras clave: Antipsicoticos, Trastorno depresivo mayor, Trastorno depresivo resistente al tratamiento, Quinolonas,Tiofenos. Resumen: To assess the efficacy, tolerability, and safety of brexpiprazole as adjunctive therapy to antidepressant treatments (ADTs) in adults with major depressive disorder (as defined by DSM-IV-TR criteria) and inadequate response to ADTs. Link: ./index.php?lvl=notice_display&id=21880
